| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Brain fog | 5 | 7 | |
| Support brain health | 5 | 4 | |
| General health | 3 | 4 | |
| Fibromyalgia | 2 | 3 | |
| Amyotrophic lateral sclerosis | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 2 | |
| None | 4 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Brain fog | 5 | 7 | |
| Support brain health | 5 | 4 | |
| General health | 3 | 4 | |
| Fibromyalgia | 2 | 3 | |
| Amyotrophic lateral sclerosis | 1 | 0 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 2 | |
| None | 4 |